|
|
 |
| |
|
Home > Drug Companies > MedImunne Inc.
MedImunne Inc.
MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. The company has four marketed products and an advancing pipeline of promising candidates, all designed to treat or prevent a number of debilitating or life threatening diseases.
The firm is the first monoclonal antibody successfully developed to combat infectious disease, and is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus in pediatric patients at high risk of Respiratory Syncytial Virus called as RSV disease. Ethyol is a selective cytoprotective agent used to reduce certain toxicities associated with cancer chemotherapy and radiotherapy.
The information contained in their Providers' Guide is intended for use by healthcare providers within the United States as educational information and not as medical advice.In addition to commercial strengths, MedImmune's research and development pipeline features product opportunities in important and diverse areas including projects that may impact women's health.
This also includes vaccines to prevent cervical cancer caused by human papillomavirus, projects that may continue to address the quality of life of infants and children, including new generations of antibody based RSV protection vaccines that may one day prevent RSV and parainfluenzavirus disease, human metapneumovirus infection, and Streptococcus pneumoniae infections, the leading cause of otitis media; antibodies that may one day aid cancer patients in fending off tumor growth and metastasis; and antibodies that may enable an asthma sufferer to block the debilitating asthmatic response.
Their vision is to lead the way to a healthier world. By carrying out this vision at every level of our organization, we will be recognized by our employees, customers and shareholders as the best pharmaceutical company in the world, resulting in value.
Back to Drug Companies
|
|
|
|
|
|
|
|